Related references
Note: Only part of the references are listed.Magnetic Resonance Imaging as a Potential Surrogate for Relapses in Multiple Sclerosis: A Meta-analytic Approach
Maria Pia Sormani et al.
ANNALS OF NEUROLOGY (2009)
MRI as an outcome in multiple sclerosis clinical trials
M. Daumer et al.
NEUROLOGY (2009)
Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis
Marco Rovaris et al.
MULTIPLE SCLEROSIS (2008)
Magnetic resonance imaging as a surrogate outcome for multiple sclerosis relapses
J. Petkau et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
T1-and T2-based MRI measures of diffuse gray matter and white matter damage in patients with multiple sclerosis
Mohit Neema et al.
JOURNAL OF NEUROIMAGING (2007)
Predictors of relapse rate in MS clinical trials
U Held et al.
NEUROLOGY (2005)
Does the Prentice criterion validate surrogate endpoints?
VW Berger
STATISTICS IN MEDICINE (2004)
MRI metrics as surrogate endpoints for EDSS progression in SPMS patients treated with IFN β-lb
MP Sormani et al.
NEUROLOGY (2003)
Statistical challenges in the evaluation of surrogate endpoints in randomized trials
G Molenberghs et al.
CONTROLLED CLINICAL TRIALS (2002)
Randomized controlled trial of interferon-beta-1a in secondary progressive MS - MRI results
DKB Li et al.
NEUROLOGY (2001)
Share Paper
